These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5337751)

  • 21. [Transitory exacerbations arising during the course of neuroleptic therapy].
    Gurovich IIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients.
    Ananth JV; Horodesky S; Lehmann HE; Ban TA
    Laval Med; 1970 Sep; 41(7):934-8. PubMed ID: 5509491
    [No Abstract]   [Full Text] [Related]  

  • 23. [Catatonia and extrapyramidal syndrome].
    Ostaptzeff ; Ostaptzeff-Lavoine
    Ann Med Psychol (Paris); 1970 Jul; 2(2):256-61. PubMed ID: 5475411
    [No Abstract]   [Full Text] [Related]  

  • 24. A preliminary study of Thiothixene in chronic schizophrenics.
    Simpson GM; Iqbal J
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):697-700. PubMed ID: 4953690
    [No Abstract]   [Full Text] [Related]  

  • 25. [Early paroxysmal extrapyramidal accidents due to neuroleptic medication].
    MANCEAUX AG; SUTTER JM; PELICIER Y; GIRARD Y; ESCOUTE R
    Rev Otoneuroophtalmol; 1957; 29(5):275-8. PubMed ID: 13518929
    [No Abstract]   [Full Text] [Related]  

  • 26. [Extrapyramidal motor side-effects of neuroleptic therapy & their treatment].
    HARTMANN K; HIPPIUS H
    Arztl Wochensch; 1959 Apr; 14(16):307-12. PubMed ID: 13649487
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
    Castaigne P; Lapresle J; Chain F
    Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
    [No Abstract]   [Full Text] [Related]  

  • 28. [Psychiatry and immunology: contribution to experimental study of the immunodepressive effect of a corrector of extrapyramidal syndromes induced by neuroleptics: ethybenzatropine].
    Borenstein P; Schneider M; Hayat M; Mascaro G; Cujo P
    Ann Med Psychol (Paris); 1971 Mar; 1(3):424-30. PubMed ID: 5558677
    [No Abstract]   [Full Text] [Related]  

  • 29. [Adverse effects of neurolepitcs from the biochemical viewpoint].
    Kluge H; Hartmann W; Wieczorek V
    Z Arztl Fortbild (Jena); 1974 Nov; 68(22):1207-9. PubMed ID: 4156445
    [No Abstract]   [Full Text] [Related]  

  • 30. [Management of schizophrenic psychoses using low-potency neuroleptics].
    Kemperdick KT; Nieling C; Steinig A
    Med Klin; 1967 Sep; 62(39):1512-5. PubMed ID: 5596490
    [No Abstract]   [Full Text] [Related]  

  • 31. [New types of neurological complications caused by a new neuroleptic drug, prochlorperazine].
    DELAY J; DENIKER P; FOURMENT J; GREEN A; ROPERT M
    Ann Med Psychol (Paris); 1957 Mar; 115(3):510-5. PubMed ID: 13411734
    [No Abstract]   [Full Text] [Related]  

  • 32. [Orolingual dyskinesia caused by prolonged neuroplegic therapy].
    Fenyvesi T
    Orv Hetil; 1968 Sep; 109(39):2149-52. PubMed ID: 5716904
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug induced functional disorders of the tongue, pharynx and larynx].
    Bauer H
    Z Laryngol Rhinol Otol; 1967 Mar; 46(3):154-9. PubMed ID: 4870673
    [No Abstract]   [Full Text] [Related]  

  • 34. [Side effects of neuroleptics in compound preparations].
    Schulte PW; Zimmermann H
    Med Klin; 1971 Nov; 66(48):1644-8. PubMed ID: 4400005
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of mesoridazine (TPS-23) with psychotic patients].
    Marquis PA; Bury JA; Pomerleau G
    Can Psychiatr Assoc J; 1968 Dec; 13(6):513-20. PubMed ID: 5726836
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 38. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neuropathy due to drug therapy].
    Kato Y
    Nihon Rinsho; 1970 Mar; 28(3):505-9. PubMed ID: 4315541
    [No Abstract]   [Full Text] [Related]  

  • 40. [Utilization of thiothixene in the treatment of mania: Pilot study].
    Filotto J; Bordeleau JM; Tetreault L
    Can Psychiatr Assoc J; 1968 Apr; 13(2):175-9. PubMed ID: 5662268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.